"Transmission of documents via telephone wires is possible in principle, but the apparatus required is so expensive that it will never become a practical proposition."
Dennis Gabor, British physicist
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7094429 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 08/22/2006 |
| 6869618 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 03/22/2005 |
| 6703376 | Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients A method of promoting drainage of mucous secretions in the congested airways of a bedridden/immobilized patient or an intubated/mechanically-ventilated patient is disclosed. The method comprises administering to the airways of the patient a uridine phosph... | 03/09/2004 |
| 6670370 | Dextromethorphan tannate The invention pertains to a composition comprising dextromethorphan tannate and to a method for preparing dextromethorphan tannate by reacting dextromethorphan at a temperature of about 80 to about 180° C. with tannic acid either neat or as an aqueous sl... | 12/30/2003 |
| 6558618 | Anti-infection formulation and delivery method A method of dispersing, in water vapor, an anti-infective therapeutic composition (10) into the air in a room (36), in order to treat or prevent transmission of upper respiratory infections, includes: adding to a reservoir of liquid water in a vaporizer (... | 05/06/2003 |
| 6440465 | Topical composition for the treatment of psoriasis and related skin disorders Compositions and methods of use thereof for the treatment of psoriasis and related skin ailments are disclosed. The compositions include topical skin formulations of glucosamine in an emollient base such as moisturizing cream. In addition to glucosamine, ... | 08/27/2002 |
| 6121319 | Monoesters of probucol for the treatment of cardiovascular and inflammatory disease This invention is a method and composition for the inhibition of VCAM-1, and in particular for the treatment of cardiovascular or inflammatory disease, including atherosclerosis, that includes the administration of an effective amount of an ester of probu... | 09/19/2000 |
| 6025334 | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an impr... | 02/15/2000 |
| 5994330 | Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions Treatment of acne through topical administration is an aspect of the present invention. Specifically, muscarinic agents may be applied in any therapeutically acceptable carrier including gels, creams, lotions, and sprays. Therapeutic effects observed with... | 11/30/1999 |
| 5985839 | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression: process of making thereof The present invention relates to shark cartilage extracts and to a method of producing the same, these extracts having anti-angiogenic properties (reduction of the area of blood vessels observed in vivo on experimentally induced tumors), tumor regressive ... | 11/16/1999 |
| 5939394 | Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections The present invention relates to compositions and methods for the prevention and/or treatment of allergic, autoimmune, septic shock or infectious diseases using magnesium gluconate alone or in combination with one or more antioxidants or an antiinflammato... | 08/17/1999 |
| 5889048 | Methods and compositions for treating defective cell functions A pharmaceutical formulation having immunomodulating and regenerating effect on abnormal function of cell tissue division-regulating system comprises, as an active ingredient, mercury dichloride or potassium arsenite or sodium arsenate in the amount of 0.... | 03/30/1999 |
| 5766610 | Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof Novel pharmaceutically/cosmetically-active polycyclic aromatic compounds have the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a)-(e): ##STR2## and are useful for the treatment of a wide variety of disease... | 06/16/1998 |
| 5698537 | Method of lowering the viscosity of mucus The use of phospholipids of the following formula to reduce the viscosity of mucus in a patient is described: ##STR1## wherein one of X, Y, or Z represent: ##STR2## in which each R represents hydrogen or methyl, and each of the other two of... | 12/16/1997 |
| 5560913 | Pharmaceutical compositions The present invention relates to orally ingestible, pharmaceutical compositions containing at least one pharmaceutical active and a taste masking component.... | 10/01/1996 |
| 5534552 | Clear non-alcoholic sinus and allergy medication A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes which adversely affect many allergy sufferers. Said relief i... | 07/09/1996 |
| 5441938 | Factors which regulate macrophage antibacterial activity A novel therapy for Pseudomonas aeruginosa infections, in particular in cystic fibrosis patients, is described. Macrophages provide the first line of defence in protecting the lung against bacterial infections. Nonetheless, Pseudomonas aeruginosa infectio... | 08/15/1995 |
| 5409907 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 04/25/1995 |
| 5401728 | Lecithin based topical liniment A soybean lecithin based topical liniment and method of making the same is disclosed. The liniment utilizes soybean lecithin as a base and major ingredient and as the emulsifier which is mixed with plant oils, natural menthol, calcium stearate, and magnes... | 03/28/1995 |
| 5279828 | Ingestible mixture containing chuchuhuasha extract An ingestible mixture containing the extract from the chuchuhuasha plant is useful for the alleviation of cramps, colds, and nasal congestion. The mixture comprises: the therapeutic component being the extract from the chuchuhuasha plant; a taste and ferm... | 01/18/1994 |
| 5276061 | Cosmetic compositions containing 1-hydroxyvitamin D homologs Compositions containing 1-hydroxyvitamin D homolog compounds in a suitable carrier and methods employing such compositions are disclosed for cosmetic uses in the treatment of various skin conditions such as lack of adequate skin firmness, wrinkles,... | 01/04/1994 |
| 5272137 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 12/21/1993 |
| 5213803 | Antiviral composition and method A method utilizing compositions for topical application which are adapted for the prevention and treatment of viral infections such as Herpes, AIDS and other envelope virus infections are disclosed. The compositions of the present invention produce a syne... | 05/25/1993 |
| 5135934 | 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents Dihydrobenz[c]acridine carboxylic acid derivatives are provided which are useful for the treatment and/or prevention of organ transplantation rejection, graft versus host disease, autoimmune diseases, psoriasis and chronic inflammatory diseases.... | 08/04/1992 |
| 5104657 | Combination preparations containing chloramphenicol, gentamicin and nystatin as active ingredients for the topical treatment of inflammatory skin disorders The invention relates to combination preparations containing chloramphenicol, gentamicin, nystatin and optionally a cortisone as active ingredients for the topical treatment of inflammatory skin disorders. The preparations are present preferably in the fo... | 04/14/1992 |
| 5080906 | Method and composition for oral administration of N-acetylcysteine The blood level of orally administered N-acetylcysteine is substantially increased in a mammal when the N-acetylcysteine is administered in combination with tris(hydroxymethyl)aminomethane or a pharmaceutically acceptable salt thereof, in a molar ratio of... | 01/14/1992 |
| 5047428 | Expectorant comprising hydroxyalkylcysteine derivative An expectorant comprising a hydroxyalkylcysteine derivative of the following formula (I) is disclosed. ##STR1## wherein n represents an integer of 1 to 4. The expectorant is stabile, has little side effects and toxicity, and exhibits an excellent exp... | 09/10/1991 |
| 5013716 | Unpleasant taste masking compositions and methods for preparing same The present invention pertains to an unpleasant taste masking composition which comprises a flavoring agent having a bitter taste or unpleasant off-note and a sufficient amount of a non-bitter intense sweetener to nullify the taste or off-note of the flav... | 05/07/1991 |
| 4963533 | Therapeutic application of dideoxycytidinene The present invention relates to a composition containing the compound 2', 3'-dideoxycytidinene which has an antiviral effect against human immunodeficiency virus (HIV) and may therefore be used as a therapeutic agent for the treatment of AIDS and AIDS re... | 10/16/1990 |
| 4927631 | Decongestant preparation A decongestant preparation is disclosed which comprises a set of active components and a petrolatum base wherein the active components consist essentially of menthol, camphor, eucalyptus oil, and spirits of turpentine, wherein the total concentration of t... | 05/22/1990 |
| 4906665 | Hydroxyalkylcysteine derivative and expectorant containing the same Novel hydroxyalkylcysteine derivatives of the following formula (I) and an expectorant comprising the same are disclosed. ##STR1## wherein n represents an integer of 5 to 24. The expectorant is stabile, has little side effects and toxicity, and exhib... | 03/06/1990 |
| 4885290 | Immunoregulator comprising a derivative of estradiol Disclosed herein is an immunoregulator comprising a derivative of estradiol represented by the formula (I), which immunoregulator has a small influence to the non-specific immunoreactions in general and gives a specific influence to the immunoreactions ag... | 12/05/1989 |
| 4812449 | In situ active compound assembly Differences in microenvironments associated with various cells and other conditions in this environment are used to advantage in effecting the in situ construction of biologically active agents at target locations in preference to surroundings which are d... | 03/14/1989 |
| 4737519 | Substituted naphthalenes, indoles, benzofurans, and benzothiophenes as lipoxygenase inhibitors The present invention provides certain novel substituted naphthalenes, indoles, benzofurans, and benzothiophenes of Formula I which are useful as inhibitors of leukotriene biosynthesis and as inhibitors of lipoxygenase. They are thus employed wherever it ... | 04/12/1988 |
| 4717727 | Esters of pyridine-2,4- and 2,5-dicarboxylic acid as medicaments for the inhibition of proline hydroxylase and lysine hydroxylase Esters of pyridine-2,4- and -2,5-dicarboxylic acid act as inhibitors of proline hydroxylase and lysine hydroxylase and are suitable as fibrosuppressants and immunosuppressants, in particular for the treatment of disturbances of the metabolism of collagen ... | 01/05/1988 |
| 4707354 | Mature skin treatment and protectant compositions and methods of using same There are disclosed sunscreen, protectant, moisturizing dermatological compositions and methods for administration of such compositions to human skin in a manner such that a high degree of epidermal, especially stratum corneum, rehydration is attained in ... | 11/17/1987 |
| 4482709 | Inclusion compounds of cyclodextrin with sulfur-containing compounds This invention relates to inclusion compounds of cyclodextrin with the compounds of the general formula [I] and salts thereof, which show pharmacological effects (for example antihypertensive effect), ##STR1## wherein A is straight or branched lower ... | 11/13/1984 |
| 4137420 | Cysteine derivatives This invention relates to the compounds: N-(mercaptoacy)-cysteine represented by the following formula wherein Z is selected from the group consisting of CH3 --CH | 01/30/1979 |